Table 4.
Target | PROTAC | PROTAC structure | Cancer | Ref | Target | PROTAC | PROTAC structure | Cancer | Ref |
---|---|---|---|---|---|---|---|---|---|
PD-L1 | P22 | NSCLC TNBC, M | [215] | FKBP12 | dFKBP-1 | AML | [12] | ||
BTK | DD-04-015 | DLBCL | [161] | FKBP12 | dTAG-13 | AML | [225] | ||
BTK | P13I | BL, DLBCL, MCL | [216] | FKBP12 | RC32 | T-ALL, BL, PC, BC, CC | [226] | ||
BTK | RC-3 | BL, MCL, CML | [217] | FKBP12 | KB02-SLF | / | [97] | ||
BTK | RC-1 | AML, MCL | [227] | HPK1 | SS44 |
BL, MM, CML, et al |
[220] | ||
BTK | BC5P | AML | [219] | IDO1 | degrader 2c | CC | [221] | ||
BTK | DD-03-171 | MCL, DLBCL | [218] | IKZF1/3 | DD-03-171 | MCL, DLBCL | [218] | ||
BTK | compound 10 | BL, AML | [228] | IRAK4 | degrader-5 | DLBCL | [229] | ||
BTK | PROTAC 7 | BL, CML | [118] | ITK | TL12-186 | AML, T-ALL | [161] | ||
STAT3 | SD-36 | AML, ALCL | [57] | JAK | JP-6 | AML | [222] | ||
CD147 | compound 6a | M | [230] | Lin28 | ORN3P1 | CML | [18] | ||
PDE4 | SNIPER(PDE4)-9 | FS | [89] | PRC2 | PROTAC 1 | DLCBL | [231] | ||
PDEδ | compound 17f | CRC | [232] | PRMT5 | MS4322 | BC | [233] | ||
PDEδ | PROTAC 3 | T-ALL, PaC, CC | [234] | Rpn13 | WL-40 | MM | [235] | ||
Pirin | CCT367766 | OC | [236] | SHP2 | SHP2-D26 | EC, AML | [223] | ||
PRC2 | UNC6852 | CC, DLCBL | [237] | TBK1 | PROTAC 3i | NSCLC | [238] |